Abstract
In 2007, the orthopedic biomaterials market was valued at over $2.6 billion,
growing at an associated CAGR of 12.9% by 2014.There is great promise in the
future performance of the orthopedic biomaterials market. To date there has
been a multitude of products introduced to the market, with some becoming
spectacular successes. Future growth for this market will be a result of
continued improvements in product technology to meet the needs of patients.
This comprehensive report covers a number of disciplines, including spinal
surgery, sports medicine, tissue donation and biotechnology. In each segment
of this report, current market conditions are examined. Furthermore, the
behavior of each sub-segment over the forecast period is examined in depth.
| 
View Cart
